We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » First-Ever ‘Basket Study’ of Cancer Mutations Shows Positive Results
First-Ever ‘Basket Study’ of Cancer Mutations Shows Positive Results
September 10, 2015
A first-of-its-kind “basket study” of responses to Daiichi Sankyo and Genentech’s Zelboraf on a host of cancer mutations is showing positive results, Memorial Sloan Kettering Cancer Center researchers report.